glp-1 mlm GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica DietWorks GLP-1 Companion - Windmill

The widespread distribution and function of multiple GLP-1 receptor populations in the central and autonomic nervous system provide the anatomical foundation for the appetite-suppressing effects observed with GLP-1 agonist therapy

The Primary Care Companion For CNS Disorders , 27 (3)

Although experimental studies suggest potential pancreatic harm from GLP-1 RAs, robust clinical evidence demonstrates that these drugs do not increase the incidence of pancreatitis or pancreatic cancer in diverse human populations

NICE guidelines recommend GLP-1 receptor agonists for specific patient populations with type 2 diabetes

Your physician will recommend the best option

Diabetes Care, 46(Supplement_1), S1-S291.